Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Org Lett ; 21(11): 4039-4043, 2019 06 07.
Artigo em Inglês | MEDLINE | ID: mdl-31081633

RESUMO

The Mannich reaction has been used for decades to prepare many pharmaceutically important molecules. Here, using a "double-Mannich-ß-elimination" synthetic sequence, we report the synthesis and the characterization details of a novel class of ß-amino diaryldienones with prominent antiprostate cancer activity. Through these studies, we correct an erroneous structure in the current literature, present a discussion of the stereochemical outcome of a new reaction, and probe the mechanism(s) of byproduct formation through isotopic studies.


Assuntos
Cetonas/síntese química , Cetonas/química , Estrutura Molecular , Estereoisomerismo
2.
Med Res Rev ; 39(3): 910-960, 2019 05.
Artigo em Inglês | MEDLINE | ID: mdl-30565725

RESUMO

Prostate cancer (PCa) is the second most common cause of cancer-related mortality in men in the United States. The androgen receptor (AR) and the physiological pathways it regulates are central to the initiation and progression of PCa. As a member of the nuclear steroid receptor family, it is a transcription factor with three distinct functional domains (ligand-binding domain [LBD], DNA-binding domain [DBD], and transactivation domain [TAD]) in its structure. All clinically approved drugs for PCa ultimately target the AR-LBD. Clinically active drugs that target the DBD and TAD have not yet been developed due to multiple factors. Despite these limitations, the last several years have seen a rise in the discovery of molecules that could successfully target these domains. This review aims to present and comprehensively discuss such molecules that affect AR signaling through direct or indirect interactions with the AR-TAD or the DBD. The compounds discussed here include hairpin polyamides, niclosamide, marine sponge-derived small molecules (eg, EPI compounds), mahanine, VPC compounds, JN compounds, and bromodomain and extraterminal domain inhibitors. We highlight the significant in vitro and in vivo data found for each compound and the apparent limitations and/or potential for further development of these agents as PCa therapies.


Assuntos
Receptores Androgênicos/química , Receptores Androgênicos/metabolismo , Transdução de Sinais , Animais , Ensaios Clínicos como Assunto , Progressão da Doença , Humanos , Ligantes , Domínios Proteicos
3.
Org Biomol Chem ; 13(6): 1778-91, 2015 Feb 14.
Artigo em Inglês | MEDLINE | ID: mdl-25502141

RESUMO

Melanocortin receptors can be used as biomarkers to detect and possibly treat melanoma. To these ends, molecules bearing one, two, or three copies of the weakly binding ligand MSH(4) were attached to scaffolds based on phloroglucinol, tripropargylamine, and 1,4,7-triazacyclononane by means of the copper-assisted azide-alkyne cyclization. This synthetic design allows rapid assembly of multivalent molecules. The bioactivities of these compounds were evaluated using a competitive binding assay that employed human embryonic kidney cells engineered to overexpress the melanocortin 4 receptor. The divalent molecules exhibited 10- to 30-fold higher levels of inhibition when compared to the corresponding monovalent molecules, consistent with divalent binding. The trivalent molecules were only statistically (∼2-fold) better than the divalent molecules, still consistent with divalent binding but inconsistent with trivalent binding. Possible reasons for these behaviors and planned refinements of the multivalent constructs targeting melanocortin receptors based on these scaffolds are discussed.


Assuntos
Compostos Heterocíclicos/farmacologia , Pargilina/análogos & derivados , Floroglucinol/farmacologia , Propilaminas/farmacologia , Receptores de Melanocortina/antagonistas & inibidores , Células Cultivadas , Relação Dose-Resposta a Droga , Células HEK293 , Compostos Heterocíclicos/química , Humanos , Estrutura Molecular , Pargilina/química , Pargilina/farmacologia , Floroglucinol/química , Propilaminas/química , Receptores de Melanocortina/metabolismo , Relação Estrutura-Atividade
4.
Anal Biochem ; 464: 24-9, 2014 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-25058927

RESUMO

Europium chelates conjugated with peptide ligands are routinely used as probes for conducting in vitro binding experiments. The presence of unchelated Eu ions in these formulations gives high background luminescence and can lead to poor results in binding assays. In our experience, the reported methods for purification of these probes do not achieve adequate removal of unchelated metal ions in a reliable manner. In this work, a xylenol orange-based assay for the quantification of unchelated metal ions was streamlined and used to determine levels of metal ion contamination as well as the success of metal ion removal on attempted purification. We compared the use of Empore chelating disks and Chelex 100 resin for the selective removal of unchelated Eu ions from several Eu-diethylenetriaminepentaacetic acid chelate-peptide conjugates. Both purification methods gave complete and selective removal of the contaminant metal ions. However, Empore chelating disks were found to give much higher recoveries of the probes under the conditions used. Related to the issue of probe recovery, we also describe a significantly more efficient method for the synthesis of one such probe using Rink amide AM resin in place of Tentagel S resin.


Assuntos
Quelantes/química , Európio/química , Ácido Pentético/química , Peptídeos/química , Calibragem , Soluções , Espectrofotometria Atômica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA